CACNA1G explained

Calcium channel, voltage-dependent, T type, alpha 1G subunit, also known as CACNA1G or Cav3.1 is a protein which in humans is encoded by the CACNA1G gene.[1] [2] [3] It is one of the primary targets in the pharmacology of absence seizure.

Function

Cav3.1 is a type of low-voltage-activated calcium channel, also known as "T-type" for its transient on and off.[1] It is expressed in thalamocortical relay nucleus, and is responsible for the slow-wave sleep and absence seizure.[4] During a slow-wave sleep, Cav3.1 is put into burst mode, and a self-sustaining synchronous cycle between cortex and thalamus is formed, sensory inputs are isolated from cortex; while awake the thalamus should instead relay sensory inputs from outside the central nervous system. The mechanism of absence seizure has a lot in common with slow-wave sleep. Therefore, a blocker that inhibits the burst mode activation of Cav3.1 is effective in treating absence seizures. Common drugs including ethosuximide, as well as trimethadione.

See also

Notes and References

  1. Web site: Entrez Gene: CACNA1H calcium channel, voltage-dependent, T type, alpha 1H subunit.
  2. Perez-Reyes E, Cribbs LL, Daud A, Lacerda AE, Barclay J, Williamson MP, Fox M, Rees M, Lee JH . Molecular characterization of a neuronal low-voltage-activated T-type calcium channel . Nature . 391 . 6670 . 896–900 . February 1998 . 9495342 . 10.1038/36110 . 1998Natur.391..896P . 4373283 .
  3. Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J . International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels . Pharmacol. Rev. . 57 . 4 . 411–25 . December 2005 . 16382099 . 10.1124/pr.57.4.5 . 10386627 .
  4. Kopecky. Benjamin J.. Liang. Ruqiang. Bao. Jianxin. T-type Calcium Channel Blockers as Neuroprotective Agents. Pflügers Archiv . 2014. 466. 4. 757–765. 10.1007/s00424-014-1454-x. 0031-6768. 4005039. 24563219.